CT and MR imaging evaluation of hepatic adenoma

Journal of Computer Assisted Tomography

Volumn 30, Issue 5, 2006, Pages 745-750

  Brancatelli, Giuseppe ^a,b,c,e   Federle, Michael P ^b   Vullierme, Marie Pierre ^d   Lagalla, Roberto ^b   Midiri, Massimo ^b   Vilgrain, Valérie ^d  

^a NATIONAL INSTITUTE FOR DIGESTIVE DISEASES   (Italy)

^b UNIVERSITY OF PALERMO   (Italy)

^c UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^d BEAUJON HOSPITAL   (France)

^e NONE   (Italy)

Author keywords

Computed tomography; Hepatic adenoma; Liver; Magnetic resonance imaging

Indexed keywords

BIOMINERALIZATION; COMPUTERIZED TOMOGRAPHY; TUMORS;

COMPUTED TOMOGRAPHY; CONTRAST-ENHANCED CT; CONTRAST-ENHANCED MR; CT IMAGING; HAEMORRAGE; HEPATIC ADENOMA; IMAGING EVALUATION; LOW GRADE; MR IMAGING;

MAGNETIC RESONANCE IMAGING;

ANDROGEN; ORAL CONTRACEPTIVE AGENT;

ADENOMATOSIS; ARTICLE; BLEEDING; CALCIFICATION; CANCER RISK; CANCER STAGING; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DIAGNOSTIC IMAGING; HUMAN; LIVER ADENOMA; NECROSIS; NODULAR HYPERPLASIA; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOGENESIS; PRIORITY JOURNAL;

EID: 33748557775     PISSN: 03638715     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.rct.0000224630.48068.bf     Document Type: Article

References (15)

1. Foster JH, Berman MM. The malignant transformation of liver cell adenomas. Arch Surg. 1994;129:712-717.
2. Ghaferi A, Hutchins GM. Progression of liver pathology in patients undergoing the Fontan procedure: chronic passive congestion, cardiac cirrhosis, hepatic adenoma, and hepatocellular carcinoma. J Thorac Cardiovasc Surg. 2005;129:1348-1352.
3. Gyorffy EJ, Bredfeldt JE, Black WC. Transformation of hepatic cell adenoma to hepatocellular carcinoma due to oral contraceptive use. Ann Intern Med. 1989;110:489-490.
4. Edmondson HA, Henderson B, Benton B. Liver-cell adenomas associated with use of oral contraceptives. N Engl J Med. 1976;294:470-472.
5. Nime F, Pickren JW, Vana J, et al. The histology of liver tumors in oral contraceptive users observed during a national survey by the American College of Surgeons Commission on Cancer. Cancer. 1979;44:1481-1489.
6. Labrune P, Trioche P, Duvaltier I, et al. Hepatocellular adenomas in glycogen storage disease type I and III: a series of 43 patients and review of the literature. J Pediatr Gastroenterol Nutr. 1997;24:276-279.
7. Foster JH, Donohue TA, Berman MM. Familial liver-cell adenomas and diabetes mellitus. N Engl J Med. 1978;299:239-241.
8. Faria SC, Iyer RB, Rashid A, et al. Hepatic adenoma. AJR. 2004;182:1520.
9. Ichikawa T, Federle MP, Grazioli L, et al. Hepatocellular adenoma: multiphasic CT and histopathologic findings in 25 patients. Radiology. 2000;214:861-868.
10. Arrive L, Flejou JF, Vilgrain V, et al. Hepatic adenoma: MR findings in 51 pathologically proved lesions. Radiology. 1994;193:507-512.
11. Paulson EK, McClellan JS, Washington K, et al. Hepatic adenoma: MR characteristics and correlation with pathologic findings. AJR. 1994;163:113-116.
12. Chung KY, Mayo Smith WW, et al. Hepatocellular adenoma: MR imaging features with pathologic correlation. AJR. 1995;165:303-308.
13. Grazioli L, Federle MP, Ichikawa T, et al. Liver adenomatosis: clinical, histopathologic, and imaging findings in 15 patients. Radiology. 2000;216:395-402.
14. Laurent C, Trillaud H, Lepreux S, et al. Association of adenoma and focal nodular hyperplasia: experience of a single French academic center. Comp Hepatol. 2003;23:2-6.
15. Nokes SR, Baker ME, Spritzer CE, et al. Hepatic adenoma: MR appearance mimicking focal nodular hyperplasia. J Comput Assist Tomogr. 1988;12:885-887.